RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Mayer Davidson to Insulin

This is a "connection" page, showing publications Mayer Davidson has written about Insulin.
Connection Strength

8.095
  1. Davidson MB, Davidson SJ. Real-world evidence for computerized insulin dose-adjustment algorithms in the effective use of continuous glucose monitoring by primary care clinicians. Diabetes Obes Metab. 2024 Aug; 26(8):3475-3477.
    View in: PubMed
    Score: 0.834
  2. Davidson MB. A simplified straightforward protocol for the use of U-500 regular insulin. Diabetes Obes Metab. 2023 02; 25(2):634-636.
    View in: PubMed
    Score: 0.746
  3. Davidson MB. Second-generation basal insulins to initiate insulin therapy in type 2 diabetes: A need for clinical evidence before incurring increased costs. Diabetes Obes Metab. 2020 05; 22(5):719-721.
    View in: PubMed
    Score: 0.621
  4. Davidson MB. Review: Rapid-acting analogues do not differ from regular human insulin for mortality or HbA1c in type 2 diabetes. Ann Intern Med. 2019 04 16; 170(8):JC39.
    View in: PubMed
    Score: 0.583
  5. Davidson MB. Delayed response to an injection of U-500 regular insulin is not rare. J Diabetes. 2019 Jul; 11(7):519-521.
    View in: PubMed
    Score: 0.582
  6. Davidson MB. Response to comment on Grunberger "insulin analogs-are they worth it? Yes!" Diabetes Care 2014;37:1767-1770 and Davidson "insulin analogs-is there a compelling case to use them? No!" Diabetes Care 2014;37:1771-1774. Diabetes Care. 2014 Oct; 37(10):e231.
    View in: PubMed
    Score: 0.426
  7. Davidson MB. Insulin analogs--is there a compelling case to use them? No! Diabetes Care. 2014 Jun; 37(6):1771-4.
    View in: PubMed
    Score: 0.416
  8. Davidson MB. Self-mixed/split insulin regimen: a serious omission in the ADA/EASD position statement. Diabetes Care. 2014; 37(1):3-4.
    View in: PubMed
    Score: 0.404
  9. Davidson MB. Comment on: Tam et al. Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 2012;35:1605-1610. Diabetes Care. 2013 Jan; 36(1):e10.
    View in: PubMed
    Score: 0.377
  10. Davidson MB, Raskin P, Tanenberg RJ, Vlajnic A, Hollander P. A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure. Endocr Pract. 2011 May-Jun; 17(3):395-403.
    View in: PubMed
    Score: 0.336
  11. Davidson MB, Navar MD, Echeverry D, Duran P. U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients. Diabetes Care. 2010 Feb; 33(2):281-3.
    View in: PubMed
    Score: 0.303
  12. Davidson MB. Pro's and con's of the early use of insulin in the management of type 2 diabetes: a clinical evaluation. Curr Opin Endocrinol Diabetes Obes. 2009 Apr; 16(2):107-12.
    View in: PubMed
    Score: 0.291
  13. Davidson MB. No need for the needle (at first). Diabetes Care. 2008 Oct; 31(10):2070-1.
    View in: PubMed
    Score: 0.281
  14. Ogunyemi D, Jesse M, Davidson M. Comparison of glyburide versus insulin in management of gestational diabetes mellitus. Endocr Pract. 2007 Jul-Aug; 13(4):427-8.
    View in: PubMed
    Score: 0.257
  15. Ballani P, Tran MT, Navar MD, Davidson MB. Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients. Diabetes Care. 2006 Nov; 29(11):2504-5.
    View in: PubMed
    Score: 0.246
  16. Davidson MB. Starting insulin therapy in type 2 diabetic patients: does it really matter how? Diabetes Care. 2005 Feb; 28(2):494-5.
    View in: PubMed
    Score: 0.218
  17. Davidson MB. Early insulin therapy for type 2 diabetic patients: more cost than benefit. Diabetes Care. 2005 Jan; 28(1):222-4.
    View in: PubMed
    Score: 0.217
  18. Davidson MB, Dulan S, Duran P, Bazargan M. Indirect support for the use of supplemental insulin in hospitalized insulin-requiring diabetic patients. Diabetes Care. 2004 Sep; 27(9):2260-1.
    View in: PubMed
    Score: 0.212
  19. Davidson MB. Twice-Daily NPH or mixture insulins versus triple therapy: apples versus oranges: response to Poulsen et al. Diabetes Care. 2004 Jul; 27(7):1846; author reply 1847-8.
    View in: PubMed
    Score: 0.209
  20. Davidson MB. Comment on Aleppo et al. The Effect of Discontinuing Continuous Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-2737. Diabetes Care. 2022 04 01; 45(4):e84.
    View in: PubMed
    Score: 0.179
  21. Hsia SH, Davidson MB. Established therapies for diabetes mellitus. Curr Med Res Opin. 2002; 18 Suppl 1:s13-21.
    View in: PubMed
    Score: 0.176
  22. Davidson MB. Continuous Glucose Monitoring in Patients With Type 1 Diabetes Taking Insulin Injections. JAMA. 2017 01 24; 317(4):363-364.
    View in: PubMed
    Score: 0.125
  23. Davidson MB. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: response to Welschen et al. and Kleefstra et al. Diabetes Care. 2005 Oct; 28(10):2597; author reply 2597-8.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support